Selected Publications
IGVF Consortium: Deciphering the impact of genomic variation on function Nature 633 : 47-57,2024.
Riggan KA, Feys R, Kokayi A, Meagher KM, Michie M, Musunuru K, Ormond KE, Schelhaas AJ, Yap JQ, Isasi R, Allyse MA.: Grounded in reality: integrating community values and priorities of end users in human gene editing Am J Bioeth 24 : 43-45,2024.
Whittaker MN, Musunuru K.: An epigenetic editor to silence genes Science 384 : 1407-1408,2024.
Lv W, Babu A, Morley MP, Musunuru K, Guerraty MA.: Resource of gene expression data from a multiethnic population cohort of induced pluripotent stem cell-derived cardiomyocytes Circ Genom Precis Med 17 : e004218,2024.
Brooks DL, Whittaker MN, Said H, Dwivedi G, Qu P, Musunuru K, Ahrens-Nicklas RC, Alameh MG, Wang X.: A base editing strategy using mRNA-LNPs for in vivo correction of the most frequent phenylketonuria variant HGG Adv 5 : 100253,2024.
Brooks DL, Whittaker MN, Qu P, Musunuru K, Ahrens-Nicklas RC, Wang X.: Efficient in vivo prime editing corrects the most frequent phenylketonuria variant, associated with high unmet medical need Am J Hum Genet 110 : 2003-2014,2023.
Musunuru K.: Playing the genetic lottery: an interview with Kiran Musunuru Dis Model Mech 16 : dmm050508,2023.
Whittaker MN, Testa LC, Quigley A, Jindal I, Cortez-Alvarado SV, Qu P, Yang Y, Alameh MG, Musunuru K, Wang X.: Epigenome editing durability varies widely across cardiovascular disease target genes Arterioscler Thromb Vasc Biol 43 : 2075-2077,2023.
Allyse MA, Meagher KM, Michie M, Isasi R, Ormond KE, Bonhomme N, Bombard Y, Howard H, Musunuru K, Riggan KA, Rubeck S.: Translational justice in human gene editing: bringing end user engagement and policy together Am J Bioeth 23 : 55-58,2023.
Testa LC, Musunuru K.: Base editing and prime editing: potential therapeutic options for rare and common diseases BioDrugs 37 : 453-462,2023.
Academic Contact Information
3400 Civic Center Blvd, Bldg 421
11-104 Smilow Center for Translational Research
Philadelphia,
PA
19104
Phone: 215-573-4717